Status:
COMPLETED
Platelets in Cystic Fibrosis Lung Inflammation
Lead Sponsor:
Mersin Training and Research Hospital
Conditions:
Platelet Levels and Mean Platelet Volume in Patients With CF
Eligibility:
All Genders
12-18 years
Brief Summary
Cystic fibrosis (CF) is a chronic multiorgan disorder caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Chronic airway infection by bacterial pathogens accoun...
Detailed Description
Airway inflammation in CF is predominantly neutrophilic in nature with increased concentrations of pro-inflammatory mediators include TNF-α, IL-1β, IL-6, IL-8, IL-17, IL-33, GM-CSF and G-CSF. In addit...
Eligibility Criteria
Inclusion
- All regularly followed cystic fibrosis patients with clinical and laboratory results could be obtained from medical charts.
Exclusion
- None
Key Trial Info
Start Date :
April 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT05339724
Start Date
April 8 2022
End Date
May 1 2022
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mersin City Research & Training Hospital
Mersin, Turkey (Türkiye)